What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions.
Open accessThe DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mobile health (mHealth) is often reputed to be cost-effective or cost-saving. Despite optimism, the strength of the evidence supporting this assertion has been limited. In this systematic review the body of evidence related to economic evaluations of mHealth interventions is assessed and summarized. METHODS: Seven electronic bibliographic databases, grey literature, and relevant references were searched. Eligibility criteria included original articles, comparison of costs and consequences of interventions (one categorized as a primary mHealth intervention or mHealth intervention as a component of other interventions), health and economic outcomes and published in English. Full economic evaluations were appraised using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist and The PRISMA guidelines were followed. RESULTS: Searches identified 5902 results, of which 318 were examined at full text, and 39 were included in this review. The 39 studies spanned 19 countries, most of which were conducted in upper and upper-middle income countries (34, 87.2%). Primary mHealth interventions (35, 89.7%), behavior change communication type interventions (e.g., improve attendance rates, medication adherence) (27, 69.2%), and short messaging system (SMS) as the mHealth function (e.g., used to send reminders, information, provide support, conduct surveys or collect data) (22, 56.4%) were most frequent; the most frequent disease or condition focuses were outpatient clinic attendance, cardiovascular disease, and diabetes. The average percent of CHEERS checklist items reported was 79.6% (range 47.62-100, STD 14.18) and the top quartile reported 91.3-100%. In 29 studies (74.3%), researchers reported that the mHealth intervention was cost-effective, economically beneficial, or cost saving at base case. CONCLUSIONS: Findings highlight a growing body of economic evidence for mHealth interventions. Although all studies included a comparison of intervention effectiveness of a health-related outcome and reported economic data, many did not report all recommended economic outcome items and were lacking in comprehensive analysis. The identified economic evaluations varied by disease or condition focus, economic outcome measurements, perspectives, and were distributed unevenly geographically, limiting formal meta-analysis. Further research is needed in low and low-middle income countries and to understand the impact of different mHealth types. Following established economic reporting guidelines will improve this body of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In one high-quality review, 74% of included studies found that remote monitoring through mobile devices to support data collection was cost-effective, economically beneficial, or cost saving at base case from a provider or societal perspective [64].”
From Telemedicine in the OECD: An umbrella review of clinical and cost-effectiveness, patient experience and implementation (2020) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Economic evidence of digital solutions in primary care is rare, indicating the significance of this paper to drive more research into the true economic benefit digital solutions can hold in general practice.”
From A prospective observational real world feasibility study assessing the role of app-based remote patient monitoring in reducing primary care clinician workload during the COVID pandemic (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DHIs show promise for addressing physical inactivity due to their broad accessibility, precise population targeting, and cost-effective implementation (19)”
From The effectiveness of digital health intervention on glycemic control and physical activity in patients with type 2 diabetes: a systematic review and meta-analysis (2025) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many apps are also cost-effective and may be beneficial where therapy services are limited or unavailable [35,36].”
From Efficacy, Effectiveness, and Quality of Resilience-Building Mobile Health Apps for Military, Veteran, and Public Safety Personnel Populations: Scoping Literature Review and App Evaluation (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“MHealth interventions have proven to be low cost and cost-effective across various medical specialties [18,19].”
From Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: A systematic review (2020) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Decision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Mobile Text Messaging for Health: A Systematic Review of Reviews
Hall, A. K., Cole-Lewis, H., & Bernhardt, J. M. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122855 · Cited by 815
Emerging Technologies for Next-Generation Point-of-Care Testing
Vashist, S. K., Luppa, P. B., Yeo, L. Y., Ozcan, A., & Luong, J. H. T. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.09.001 · Cited by 705
Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis
Thakkar, J., Kurup, R., Laba, T.-L., Santo, K., Thiagalingam, A., Rodgers, A., Woodward, M., Redfern, J., & Chow, C. K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7667 · Cited by 685
Research works printed but not linked: 1
- J Moore, 2014, Technology-Supported Apprenticeship in the Management of Hypertension: A Randomized Controlled Trial, JCOM, 21
Cited by
Bringing health care to the patient: An overview of the use of telemedicine in OECD countries
(2020) · OECD Health Working Papers · doi:10.1787/8e56ede7-en · Cited by 539
Digital health: a path to validation
Mathews, S. C., McShea, M. J., Hanley, C. L., Ravitz, A., Labrique, A. B., & Cohen, A. B. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0111-3 · Cited by 508
The cost-effectiveness of digital health interventions: A systematic review of the literature
Gentili, A., Failla, G., Melnyk, A., Puleo, V., Tanna, G. L. D., Ricciardi, W., & Cascini, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.787135 · Cited by 444
“Standardized cost-effectiveness analysis should be used to compare different interventions in terms of their consequences and costs so it can be used as a crucial tool to help decision makers or funders understand if digital health interventions and innovations actually determine an increase of QALYs or DALYs with con…”
MethodEnablers and barriers to effective diabetes self-management: A multi-national investigation
Adu, M. D., Malabu, U. H., Malau-Aduli, A. E. O., & Malau-Aduli, B. S. (2019) · PLOS ONE · doi:10.1371/journal.pone.0217771 · Cited by 413
Eze, N. D., Mateus, C., & Cravo Oliveira Hashiguchi, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237585 · Cited by 345
“In one high-quality review, 74% of included studies found that remote monitoring through mobile devices to support data collection was cost-effective, economically beneficial, or cost saving at base case from a provider or societal perspective [64].”
Background
Metadata
- Authors
- Iribarren, S. J., Cato, K., Falzon, L., & Stone, P. W.
- Affiliations
- University of Washington (US)
- NewYork–Presbyterian Hospital (US)
- Columbia University (US)
- Corresponding author
- Iribarren, Sarah J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-02-02
- Volume
- 12
- Issue
- 2
- Pages
- e0170581
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5289471
- OpenAlex
- W2585436378
- Semantic Scholar
- 0d33b0e5ba62782ffd64ff9fe7be9cffd7f1aaa7
- Cited by
- 519
- References
- 72
- Citations by year
- 2026: 27 · 2025: 50 · 2024: 61 · 2023: 48 · 2022: 86 · 2021: 100 · 2020: 68 · 2019: 50 · 2018: 23 · 2017: 6
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Columbia Academic Commons (Columbia University)
- Funders
- National Institute of Nursing Research (T32NR014205)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- mobile health, economic evaluation, cost-effectiveness, health technology assessment, reporting quality, CHEERS checklist, short message service, behavior change communication, medication adherence, outpatient visits, diabetes mellitus, cardiovascular disease, low- and middle-income countries
- MeSH terms
- Cost-Benefit Analysis, Economics, Medical, Humans, Telemedicine, Cell Phone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. https://app.cochat.ai/papers/10.1371/journal.pone.0170581
- The paper
- Iribarren, S. J., Cato, K., Falzon, L., & Stone, P. W. (2017). What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLOS ONE. https://doi.org/10.1371/journal.pone.0170581
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

